Functional outcome in patients with critical illness polyneuropathy

Disability and Rehabilitation
M van der SchaafRien de Vos

Abstract

To evaluate the functional outcome of intensive care patients with critical illness polyneuropathy (CIP), 6 and 12 months after the onset. A prospective observational cohort study and a cross-sectional study. University hospital in the Netherlands. Eight consecutive intensive care patients with CIP for the prospective study and eight patients diagnosed with CIP in the past 6 months for the cross-sectional study. Functional outcome regarding body functions and structure, activities, participation and perceived quality of life. Nine patients (56%) died within one year. Functional outcome, participation and subjective health status in survivors varied widely at 6 and 12 months. After 12 months, physical functioning was improved in all patients. However activities related to mobility outdoors, autonomy, participation and quality of life were restricted in most patients. The majority of survivors have persistent functional disabilities in activities, reduced quality of life and restrictions in autonomy and participation one year after the onset of CIP. Prolonged rehabilitation treatment is necessary for an increasing number of intensive care patients who develop CIP, in order to reduce handicaps and achieve optimal autonomy and soci...Continue Reading

References

Feb 1, 1991·Journal of the American Geriatrics Society·D Podsiadlo, S Richardson
Aug 1, 1987·Brain : a Journal of Neurology·D W ZochodneW A Sibbald
Oct 1, 1985·Critical Care Medicine·W A KnausJ E Zimmerman
Nov 1, 1984·Journal of Neurology, Neurosurgery, and Psychiatry·C F BoltonW J Sibbald
Oct 18, 1995·JAMA : the Journal of the American Medical Association·F S LeijtenA W de Weerd
Jul 1, 1995·Archives of Physical Medicine and Rehabilitation·S R Jarrett, J S Mogelof
Jan 1, 1993·Intensive Care Medicine·C F Bolton
Feb 1, 1994·Clinical Neurology and Neurosurgery·F S Leijten, A W de Weerd
Dec 22, 1993·JAMA : the Journal of the American Medical Association·J R Le GallF Saulnier
Sep 1, 1996·Intensive Care Medicine·K BerekN J Mutz
Oct 3, 1998·Intensive Care Medicine·J H CoakleyC J Hinds
Jul 9, 1999·Critical Care Medicine·M NiskanenA Kari
Feb 24, 2001·Disability and Rehabilitation·M van der SchaafI J de Groot
Jan 7, 2004·Critical Care Medicine·Lakshmipathi ChelluriMichael R Pinsky

❮ Previous
Next ❯

Citations

Oct 14, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·L H Visser
Dec 2, 2008·Critical Care : the Official Journal of the Critical Care Forum·Greet HermansGreet Van den Berghe
Nov 26, 2008·Disability and Rehabilitation·Marike van der SchaafFrans Nollet
Jul 30, 2009·AACN Advanced Critical Care·Ramona O Hopkins, Vicki J Spuhler
Aug 21, 2012·Critical Care Medicine·Marike van der SchaafDave A Dongelmans
May 3, 2011·Critical Care Medicine·Elizabeth H SkinnerLinda Denehy
Jun 22, 2010·Critical Care Medicine·Mathieu van der Jagt
Nov 10, 2013·Critical Care Medicine·Goele VanpeeRik Gosselink
Feb 6, 2010·Critical Care Medicine·Jean-Louis Vincent, Michelle Norrenberg
May 13, 2008·Intensive & Critical Care Nursing : the Official Journal of the British Association of Critical Care Nurses·Carol Ball
Feb 15, 2007·Current Treatment Options in Neurology·Shawn J Bird
Jul 15, 2005·Current Opinion in Critical Care·Nicola LatronicoElisa Seghelini
Sep 13, 2005·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Lois C FriedmanJames Lomax
May 1, 2015·Journal of the Intensive Care Society·Richard Td AppletonTara Quasim
Oct 30, 2012·Medizinische Klinik, Intensivmedizin und Notfallmedizin·A GrimmH Axer
Oct 24, 2007·British Journal of Hospital Medicine·Christine Collin
Jan 26, 2021·Pain Reports·Christine H Meyer-FrießemElena K Enax-Krumova

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.